Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Icecure Medical Ltd Ord (ICCM)

Icecure Medical Ltd Ord (ICCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response Newswire.ca - Tue Apr 30, 9:30AM CDT

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.1200 (+0.90%)
ICCM : 1.0446 (+0.44%)
ATOS : 1.5600 (-0.64%)
ARVN : 33.44 (+2.33%)
PFE : 28.69 (+0.17%)
ONC.TO : 1.51 (-2.58%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate BayStreet.ca - Tue Apr 30, 9:04AM CDT

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.1200 (+0.90%)
ONC.TO : 1.51 (-2.58%)
ICCM : 1.0446 (+0.44%)
ATOS : 1.5600 (-0.64%)
ARVN : 33.44 (+2.33%)
PFE : 28.69 (+0.17%)
Renowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023 PR Newswire - Fri Sep 22, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.0446 (+0.44%)
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer PR Newswire - Wed Sep 20, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by...

ICCM : 1.0446 (+0.44%)
IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress PR Newswire - Fri Sep 8, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.0446 (+0.44%)
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America PR Newswire - Mon Aug 28, 2023

Mr. Shad Good brings nearly 20 years of medical device sales and leadership experience, including as U.S. Senior Director of Sales at a global leader in...

ICCM : 1.0446 (+0.44%)
IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.0446 (+0.44%)
IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023 PR Newswire - Mon Aug 7, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.0446 (+0.44%)
Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System PR Newswire - Mon Jul 24, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.0446 (+0.44%)
IceCure Medical Expands Distribution of ProSense® into Portugal Through Agreement with Medicinália Cormédica: Upfront Systems & Probes Sales PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...

ICCM : 1.0446 (+0.44%)

Barchart Exclusives

Is It Too Late to Buy the Best Dow Stock of 2024? Barchart - 11 minutes ago
As the Dow Jones reaches record highs and American Express leads the pack, is it too late to snag a piece of the stock? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot